See Which of These Two Surging Biotech Stocks Hedge Funds Approve On

Page 2 of 2

The second biotech stock that appreciated today is Capnia Inc (NASDAQ:CAPN)‘s, which has grown by over 14% so far today also on the back of product data. Earlier today, the company said that it had released a paper titled “Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis” that discusses the efficiency of CoSense End-Tidal Carbon Monoxide Monitor at detecting hemolysis in jaundiced newborns. However, despite the 78% growth of the stock year-to-date, Capnia Inc (NASDAQ:CAPN) still has a market cap of around $25 million and still has to capture the attention of investors, because, as of the end of June, none of the funds from our database own shares of Capnia Inc (NASDAQ:CAPN). However, the company has had a number of bullish signals from insiders, including a recent acquisition of 15,000 shares by board director and large shareholder Ernest Mario and 7,500 shares bought by Senior Vice President and Chief Financial Officer David D. O’Toole.

Follow Soleno Therapeutics Inc (NASDAQ:SLNO)

Disclosure: none

Page 2 of 2